Bioniq’s valuation increases to $82m

Football legend Cristiano Ronaldo has announced a new investment in AI-driven personalised supplements based on blood test data solutions provider Bioniq. Ronaldo’s ‘significant investment’ has seen the company’s valuation rise to $82 million with the Portuguese superstar aiming to increase his commitment to ‘optimising health and performance, both on and off the field.’ Ronaldo will also take part in brand and product innovations.

Cristiano Ronaldo, commented,

“Backing Bioniq goes beyond just an investment opportunity for me—it’s about aligning with a shared vision for health, performance, and longevity. I have been using their products myself for almost three years. With their personalised health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer.”

Vadim Fedotov, Co-Founder and CEO of Bioniq, said,

“Cristiano Ronaldo is the perfect partner and shareholder. As the ultimate embodiment of performance and longevity, Cristiano fully aligns with the values and mission of Bioniq. We are thrilled that the world’s leading athlete and advocate of a healthy lifestyle has made Bioniq part of his journey since 2022. His personal experience with our products reinforces his belief in what we’re building. Cristiano’s decision to invest highlights his confidence in our team’s vision and his commitment to helping us build the leading company in personalised health.”